Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 160

1.

The ultimate solution to the problem of aspirin resistance.

Kottke BA.

J Am Coll Cardiol. 2008 Oct 7;52(15):1276; author reply 1277. doi: 10.1016/j.jacc.2008.06.041. No abstract available.

3.

Problems in the measurement of Lp(a) (millimoles per liter versus milligrams percent).

Kottke BA.

J Am Coll Cardiol. 2001 Nov 1;38(5):1584-5. No abstract available.

4.

Executive Summary: Pivotal Research in Cardiovascular Syndromes in the Elderly.

McKay CR, Rich MW, Vlietstra RE, Kitzman DW, Fleg JL, Krumholz HM, Lakatta EG, Cooke JP, Cannon CP, Ezekowitz MD, Frohlich ED, Jalife J, Kass DA, Kottke BA, Muller JE, Saltin B, Shen WK, Somers VK.

Am J Geriatr Cardiol. 2000 Oct;9(5):243-250.

PMID:
11416575
5.

Very-low-density lipoprotein subfraction composition and metabolism by adipose tissue.

Fisher RM, Miles JM, Kottke BA, Frayn KN, Coppack SW.

Metabolism. 1997 Jun;46(6):605-10.

PMID:
9186293
6.

The effect of the treatment of hypothyroidism and hyperthyroidism on plasma lipids and apolipoproteins AI, AII and E.

O'Brien T, Katz K, Hodge D, Nguyen TT, Kottke BA, Hay ID.

Clin Endocrinol (Oxf). 1997 Jan;46(1):17-20.

PMID:
9059553
7.

HDL subparticles and coronary artery disease in NIDDM.

O'Brien T, Nguyen TT, Hallaway BJ, Hodge D, Bailey K, Kottke BA.

Atherosclerosis. 1996 Apr 5;121(2):285-91.

PMID:
9125302
8.
9.

Increase in total plasma homocysteine concentration after cardiac transplantation.

Berger PB, Jones JD, Olson LJ, Edwards BS, Frantz RP, Rodeheffer RJ, Kottke BA, Daly RC, McGregor CG.

Mayo Clin Proc. 1995 Feb;70(2):125-31.

PMID:
7845037
10.
11.

The role of lipoprotein A-I and lipoprotein A-I/A-II in predicting coronary artery disease.

O'Brien T, Nguyen TT, Hallaway BJ, Hodge D, Bailey K, Holmes D, Kottke BA.

Arterioscler Thromb Vasc Biol. 1995 Feb;15(2):228-31.

PMID:
7749830
12.

Serum lipid responses to a eucaloric high-complex carbohydrate diet in different obesity phenotypes.

Roust LR, Kottke BA, Jensen MD.

Mayo Clin Proc. 1994 Oct;69(10):930-6.

PMID:
7934189
13.

A fluorescence-conjugated immunobinding assay for the detection of P-selectin on platelets.

Wen D, Nguyen TT, Plumhoff EA, Pineda AA, Bowie EJ, Kottke BA.

J Lab Clin Med. 1994 Sep;124(3):447-54.

PMID:
7521896
14.

Effect of heparin-binding growth factor-1 on bronchial healing in canine lung allograft transplantation.

Rastogi A, Kottke BA, Tazelaar HD, Ritman EL, Bailey KR, McGregor CG.

J Heart Lung Transplant. 1994 Jul-Aug;13(4):704-13.

PMID:
7524676
15.

Lipids and Lp(a) lipoprotein levels and coronary artery disease in subjects with non-insulin-dependent diabetes mellitus.

O'Brien T, Nguyen TT, Harrison JM, Bailey KR, Dyck PJ, Kottke BA.

Mayo Clin Proc. 1994 May;69(5):430-5.

PMID:
8170193
16.

Lipoproteins and apolipoproteins. Making use of their metabolic properties to individualize therapy.

Kottke BA.

Postgrad Med. 1994 Feb 1;95(2):51-3, 57-8, 63-5. Review.

PMID:
8309863
17.

Immunomagnetic separation of subpopulations of apolipoprotein A-I.

Rastogi A, Bren ND, Hallaway BJ, Kottke BA.

Mayo Clin Proc. 1994 Feb;69(2):137-43.

PMID:
8309265
18.

Identification and quantification of apolipoproteins in addition to apo[a] and apo B-100 in human lipoprotein[a].

Blanco-Vaca F, Gaubatz JW, Bren N, Kottke BA, Morrisett JD, Guevara J Jr.

Chem Phys Lipids. 1994 Jan;67-68:35-42.

PMID:
8187234
19.

A particle concentration fluorescence immunoassay for Lp(a).

Kottke BA, Bren ND.

Chem Phys Lipids. 1994 Jan;67-68:249-56.

PMID:
8187220
21.

Treatment of and screening for hyperlipidemia.

Kottke BA.

N Engl J Med. 1993 Oct 7;329(15):1125; author reply 1127. No abstract available.

PMID:
8371742
22.

Current understanding of the mechanisms of atherogenesis.

Kottke BA.

Am J Cardiol. 1993 Sep 9;72(8):48C-53C; discussion 53C-54C. Review.

PMID:
8372801
23.

Very low density lipoprotein subfraction apolipoprotein composition.

Fisher RM, Coppack SW, Kottke BA, Miles JM.

Biochem Soc Trans. 1993 Aug;21 ( Pt 3)(3):231S. No abstract available.

PMID:
8224388
24.

Quantification of human plasma apolipoproteins C-I, C-II, and C-III by radioimmunoassays.

Bren ND, Rastogi A, Kottke BA.

Mayo Clin Proc. 1993 Jul;68(7):657-64.

PMID:
8350639
26.

Separation of high-density lipoproteins into apolipoprotein E-poor and apolipoprotein E-rich subfractions by fast protein liquid chromatography using a heparin affinity column.

O'Brien T, Buithieu J, Nguyen TT, Klein L, Bren N, Wentworth M, Hallaway BJ, Kottke BA.

J Chromatogr. 1993 Apr 2;613(2):239-46.

PMID:
8491809
27.

Insulinemia in children at low and high risk of NIDDM.

Pettitt DJ, Moll PP, Knowler WC, Mott DM, Nelson RG, Saad MF, Bennett PH, Kottke BA.

Diabetes Care. 1993 Apr;16(4):608-15.

PMID:
8462388
28.

Differential health benefits of weight loss in upper-body and lower-body obese women.

Kanaley JA, Andresen-Reid ML, Oenning L, Kottke BA, Jensen MD.

Am J Clin Nutr. 1993 Jan;57(1):20-6. Erratum in: Am J Clin Nutr 1993 Jun;57(6):953.

PMID:
8416660
30.

Apolipoprotein B quantified by particle-concentration fluorescence immunoassay.

Hallaway BJ, Rastogi A, Kottke BA.

Clin Chem. 1992 Dec;38(12):2387-91.

31.

Acute physical exercise alters apolipoprotein E and C-III concentrations of apo E-rich very low density lipoprotein fraction.

Klein L, Miller TD, Radam TE, O'Brien T, Nguyen TT, Kottke BA.

Atherosclerosis. 1992 Nov;97(1):37-51.

PMID:
1445493
32.

Low-dose, time-release nicotinic acid: effects in selected patients with low concentrations of high-density lipoprotein cholesterol.

Squires RW, Allison TG, Gau GT, Miller TD, Kottke BA.

Mayo Clin Proc. 1992 Sep;67(9):855-60.

PMID:
1434930
33.

Hypercholesterolemia and atherosclerosis in primary biliary cirrhosis: what is the risk?

Crippin JS, Lindor KD, Jorgensen R, Kottke BA, Harrison JM, Murtaugh PA, Dickson ER.

Hepatology. 1992 May;15(5):858-62.

PMID:
1568727
34.

Estimation of the frequency of isoform-genotype discrepancies at the apolipoprotein E locus in heterozygotes for the isoforms.

Mailly F, Moll P, Kottke BA, Kamboh MI, Humphries SE, Ferrell RE.

Genet Epidemiol. 1992;9(4):239-48.

35.

The gender-specific apolipoprotein E genotype influence on the distribution of lipids and apolipoproteins in the population of Rochester, MN. I. Pleiotropic effects on means and variances.

Reilly SL, Ferrell RE, Kottke BA, Kamboh MI, Sing CF.

Am J Hum Genet. 1991 Dec;49(6):1155-66. Erratum in: Am J Hum Genet 1992 Oct;51(4):942.

36.

Levels of lipids, lipoproteins, and apolipoproteins in a defined population.

Kottke BA, Moll PP, Michels VV, Weidman WH.

Mayo Clin Proc. 1991 Dec;66(12):1198-208.

PMID:
1749288
37.

Expressed hypervariable polymorphism of apolipoprotein (a).

Kamboh MI, Ferrell RE, Kottke BA.

Am J Hum Genet. 1991 Nov;49(5):1063-74.

38.

Lipoprotein analysis in the evaluation of chest pain in the emergency department.

Gay PC, Nishimura RA, Roth CS, Evans WE, Zinsmeister AR, Kottke BA.

Mayo Clin Proc. 1991 Sep;66(9):885-91.

PMID:
1921497
39.

Effects of polymorphisms in apolipoproteins E, A-IV, and H on quantitative traits related to risk for cardiovascular disease.

Kaprio J, Ferrell RE, Kottke BA, Kamboh MI, Sing CF.

Arterioscler Thromb. 1991 Sep-Oct;11(5):1330-48.

PMID:
1911720
40.

ApoA-I secretion by rabbit intestinal mucosa cell cultures.

Carlson TL, Kottke BA.

Lipids. 1991 Sep;26(9):684-8.

PMID:
1762512
41.

Predictors of intracranial carotid artery atherosclerosis. Duration of cigarette smoking and hypertension are more powerful than serum lipid levels.

Ingall TJ, Homer D, Baker HL Jr, Kottke BA, O'Fallon WM, Whisnant JP.

Arch Neurol. 1991 Jul;48(7):687-91.

PMID:
1859294
42.

Effect of coconut oil on plasma apo A-I levels in WHHL and NZW rabbits.

Carlson TL, Kottke BA.

Biochim Biophys Acta. 1991 Jun 3;1083(3):221-9.

PMID:
2049387
43.

Serum lipids and lipoproteins are less powerful predictors of extracranial carotid artery atherosclerosis than are cigarette smoking and hypertension.

Homer D, Ingall TJ, Baker HL Jr, O'Fallon WM, Kottke BA, Whisnant JP.

Mayo Clin Proc. 1991 Mar;66(3):259-67.

PMID:
2002684
44.

Niacin-induced hepatitis: a potential side effect with low-dose time-release niacin.

Etchason JA, Miller TD, Squires RW, Allison TG, Gau GT, Marttila JK, Kottke BA.

Mayo Clin Proc. 1991 Jan;66(1):23-8.

PMID:
1988755
45.
46.

Lipid and apolipoprotein levels in six Solomon Island societies differ from those in a U.S. white population.

Kottke BA, Friedlaender JS, Zerba KE, Sing CF.

Am J Phys Anthropol. 1990 Apr;81(4):483-91.

PMID:
2110417
48.
49.

Evaluation of arterialized vein graft permeability with Evans blue dye and iodine 125-labeled albumin.

Finck SJ, Mashburn JP, Kottke BA, Orszulak TA.

Ann Thorac Surg. 1989 Nov;48(5):646-50.

PMID:
2818053
50.

Lipoprotein-mediated efflux of radiolabeled cholesterol from cells does not indicate net removal of cellular cholesterol mass.

Ranganathan S, Gasman JD, Matsuura H, Kottke BA.

Biochem Cell Biol. 1989 Oct;67(10):719-23.

PMID:
2590526

Supplemental Content

Loading ...
Support Center